Allarity Therapeutics Inc...

NASDAQ: ALLR · Real-Time Price · USD
0.96
-0.02 (-2.02%)
At close: Aug 15, 2025, 2:34 PM

Allarity Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
19.53M 166K 2.03M 19.55M
Short-Term Investments
n/a n/a n/a 350K
Long-Term Investments
n/a n/a n/a 350K
Other Long-Term Assets
n/a n/a n/a 350K
Receivables
2.23M 946K 871K 1.34M
Inventory
n/a n/a n/a -1.34M
Other Current Assets
72K 78K 1.48M n/a
Total Current Assets
22.34M 1.97M 4.97M 21.05M
Property-Plant & Equipment
309K 20K 27K 94K
Goodwill & Intangibles
n/a 9.87M 9.55M 28.14M
Total Long-Term Assets
309K 9.89M 9.58M 28.58M
Total Assets
22.65M 11.86M 14.54M 49.63M
Account Payables
4.18M 8.42M 6.25M 698K
Deferred Revenue
n/a n/a n/a 8.65M
Short-Term Debt
1.35M 1.3M 2.65M 98K
Other Current Liabilities
6.58M 3.99M 2.05M 18.68M
Total Current Liabilities
10.84M 14.17M 11.22M 20.72M
Long-Term Debt
n/a n/a 1.08M 979K
Other Long-Term Liabilities
n/a n/a n/a 7.18M
Total Long-Term Liabilities
n/a 446K 1.43M 10.13M
Total Liabilities
10.84M 14.61M 12.65M 30.85M
Total Debt
1.35M 1.3M 3.73M 1.09M
Common Stock
1K n/a 2K 810K
Retained Earnings
-118.97M -94.45M -82.55M -66.49M
Comprehensive Income
-354K -411K -721K -600K
Shareholders Equity
11.81M -2.75M 1.89M 18.78M
Total Investments
n/a n/a n/a 350K